Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Getting into the AKT.

× No keyword cloud information.

4 in total

1. A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.

Authors: Brian H Kushner; Nai-Kong V Cheung; Shakeel Modak; Oren J Becher; Ellen M Basu; Stephen S Roberts; Kim Kramer; Ira J Dunkel
Journal: Int J Cancer Date: 2016-09-30 Impact factor: 7.396

2. Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma.

Authors: Birgit Geoerger; Mark W Kieran; Stephan Grupp; Danuta Perek; Jill Clancy; Mizue Krygowski; Revathi Ananthakrishnan; Joseph P Boni; Anna Berkenblit; Sheri L Spunt
Journal: Eur J Cancer Date: 2011-10-25 Impact factor: 9.162

3. Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo.

Authors: Zhijie Li; Doo-Yi Oh; Katsuya Nakamura; Carol J Thiele
Journal: Cancer Date: 2011-05-16 Impact factor: 6.860

4. Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma.

Authors: Roberta Marino; Dana C Baiu; Saswati Bhattacharya; Benjamin Titz; Ellen Hebron; Bryan D Menapace; Sorabh Singhal; Jens C Eickhoff; Fotis Asimakopoulos; Jamey P Weichert; Mario Otto
Journal: Am J Cancer Res Date: 2015-10-15 Impact factor: 6.166

4 in total